Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen PredictionDaniel K. Wells, Elham Sherafat, Marit M. van Buuren et al.|Cell|2020Cited by 534
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in MelanomaCatherine S. Grasso, Antoni Ribas, Ameya S. Champhekar et al.|Cancer Cell|2020Cited by 379
CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypesSameeha Jilani, Cristina Puig-Saus|Nature Communications|2024Cited by 50